Industry News

The University of California at Riverside is planning to construct the 110,000-sf New Genomics Building. Slated for completion by spring of 2008, the facility will provide the University's Genomics Institute with state-of-the-art research laboratories for faculty, researchers, and support staff. The design architect for the project is Shepley Bulfinch Richardson and Abbott (SBRA) working in association with RBB Architects of Los Angeles.

St. Jude Research Hospital is expanding its Memphis campus with the construction of the $114-million Integrated Patient Care and Research Building (IPCRB). Slated for completion in early 2007, the six-story, 300,000-sf building will house inpatient space, research laboratories, diagnostic imaging, and radiation oncology treatment facilities. The second floor will be dedicated to inpatient care with research and office space on the remaining floors.

Stanford University will initiate $75 million in construction work to accommodate a new laser that will be housed at the Linear Accelerator Center in Palo Alto, Calif. The project team of the San Jose office of Turner Construction and engineers Hatch Mott MacDonald are expected to begin work in early 2006. The laser is slated for operational completion in early spring 2009. The cost of new equipment and modifications to existing equipment needed to build the laser itself is over $300 million.

Texas Christian University is initiating a $100-million construction project on its Fort Worth, Texas, campus. A campus commons comprised of a university union and four residence halls will begin construction in summer 2006. The project will house a conference hall, dining facilities, space for campus activities, and dormitory space for 600 to 650 students. Funded separately, the School of Education will undergo a $10.5-million renovation and construction project.

Menlo Park, Calif.-based Bridge Pharmaceuticals is opening a 100,000-sf research facility in the Zhong-guancun Life Science Park in Beijing, China. The facility is designed to meet U.S. regulatory standards for animal testing and laboratory practice. Additionally, the contract research company is planning to acquire a preclinical testing facility in Taiwan.